Biologic Science Instruments Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-06-2024
- Paid Up Capital ₹ 2.50 M
as on 16-06-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 Cr
as on 16-06-2024
- Revenue 16.77%
(FY 2023)
- Profit 95.66%
(FY 2023)
- Ebitda 54.76%
(FY 2023)
- Net Worth 9.75%
(FY 2023)
- Total Assets 55.98%
(FY 2023)
About Biologic Science Instruments
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.50 Cr.
Vincent Helary, Varghese Samuel, Mohit Mandal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U93000MH2010PTC199463
- Company No.
199463
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jan 2010
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biologic Science Instruments Private Limited offer?
Biologic Science Instruments Private Limited offers a wide range of products and services, including Laboratory & Lab Equipment, Science Laboratory Equipment, Spectrometer, Spectro Spectrometer, Biology Equipment, Battery Tester, Battery Monitoring System, Battery Testing Equipment, Batteries & Charge Storage Devices, Battery Accessories.
Who are the key members and board of directors at Biologic Science Instruments?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Mandal  | Managing Director | 01-Sep-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varghese Samuel | Director | 29-Jan-2010 | Current |
Vincent Helary  | Director | 29-Oct-2021 | Current |
| Jean Luc | Director | 29-Oct-2021 | Current |
| Francois Goy | Director | 15-Dec-2010 | Current |
Financial Performance of Biologic Science Instruments.
Biologic Science Instruments Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.77% increase. The company also saw a substantial improvement in profitability, with a 95.66% increase in profit. The company's net worth moved up by a moderate rise of 9.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biologic Science Instruments?
In 2023, Biologic Science Instruments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 08 Feb 2017 | ₹2.00 Cr | Open |
Others Creation Date: 28 Jun 2016 | ₹5.00 M | Open |
How Many Employees Work at Biologic Science Instruments?
Unlock and access historical data on people associated with Biologic Science Instruments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biologic Science Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biologic Science Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
